shares in eco animal health group plc rose 15 on thursday after the company said that it expects revenue and earnings before interest taxes depreciation and amortization for fiscal 2023 to be slightly ahead of market expectations amid strong performance in asia shares at 0811 gmt were up 1450 pence at 11250 pence the uk maker of animal pharmaceutical products said it experienced strong performance in its final quarter with demand for its aivlosin treatment higher than expected in asia our business has delivered good progress in key international markets especially asia we look forward to providing a further update following the completion of the financial year chief executive david hallas said the company hasnt provided any forecast figures however ebitda for the year ending march 31 is forecast to be 68 million pound 83 million compared with gbp64 million in fiscal 2022 sales are forecast to be gbp847 million compared with gbp822 million both forecasts have been taken from factset and are based on an estimate by investec bank